View Older Stories View More Recent Stories

Aug 4, 2025 04:04PM BioMarin Pharma (BMRN) Tops Q2 EPS by 61c ; Offers Guidance
Jul 15, 2025 06:15AM Wolfe Research Reiterates Outperform Rating on BioMarin Pharmaceutical Inc. (BMRN)
Jul 3, 2025 07:29AM Morgan Stanley Assumes BioMarin Pharmaceutical Inc. (BMRN) at Overweight
Jul 1, 2025 08:46AM BioMarin Pharma (BMRN) Announces Completion of Acquisition of Inozyme (INZY)
Jun 25, 2025 10:03AM Jefferies Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
Jun 24, 2025 09:02AM BioMarin Pharma (BMRN) Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN at International Society on Thrombosis and Haemostasis 2025 Congress
Jun 5, 2025 12:44PM FDA Cell and Gene Therapy Roundtable 'bullish for the space' - Stifel
May 27, 2025 09:44AM Stifel Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
May 19, 2025 09:54AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised at Bernstein Following Inozyme Deal
May 16, 2025 01:11PM TD Cowen Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN) Following Inozyme Deal
May 16, 2025 12:22PM Evercore ISI on BioMarin (BMRN): 'INZY Acquisition Looks Like a Solid Addition to the Growing and Often Overlooked Enzyme Therapy Biz'
May 16, 2025 10:11AM Stifel Comments on BioMarin Pharma (BMRN): 'Acquisition of INZY A Strong Strategic Fit for BMRN; The Type of Asset That Offers Value Arbitrage'
May 16, 2025 07:31AM BioMarin Pharma (BMRN) Announces Acquisition of Inozyme Pharma (INZY) for $4 Per Share
May 12, 2025 09:06AM BioMarin Pharma (BMRN) Presents New Data for VOXZOGO in Children with Achondroplasia
May 2, 2025 10:24AM Cantor Fitzgerald Reiterates Overweight Rating on BioMarin Pharmaceutical Inc. (BMRN)
May 1, 2025 04:11PM BioMarin Pharma (BMRN) Tops Q1 EPS by 43c
Apr 21, 2025 06:46AM Oppenheimer Reiterates Outperform Rating on BioMarin Pharmaceutical Inc. (BMRN)
Apr 10, 2025 05:32AM Bernstein Recommends Three US Biotech Stocks Amid 'Heightened Regulatory Uncertainty'
Apr 2, 2025 09:06AM BioMarin Pharma (BMRN) Announces Positive Pivotal Data for PALYNZIQ in Adolescents with Phenylketonuria
Mar 20, 2025 03:57PM Citi Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 15, 2025 04:00AM How could tariffs shake up the pharma sector?
Feb 24, 2025 04:05PM BioMarin Pharma (BMRN) Appoints Timothy P. Walbert to its Board
Feb 24, 2025 07:14AM Oppenheimer Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Outperform
Feb 20, 2025 09:05AM Cantor Fitzgerald Reiterates Overweight Rating on BioMarin Pharmaceutical Inc. (BMRN)
Feb 20, 2025 07:58AM BMO Reiterates Outperform on BioMarin Pharmaceutical Inc. (BMRN) as 'Voxzogo Growth Continues'
Feb 20, 2025 07:44AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $126 at Piper Sandler; 'Strong Execution All Around'
Feb 20, 2025 07:34AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $80 at Scotiabank
Feb 20, 2025 06:46AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $91 at Stifel
Feb 19, 2025 04:35PM After-hours movers: Carvana, Klaviyo, NerdWallet, BioMarin Pharma, and more
Feb 19, 2025 04:06PM BioMarin Pharma (BMRN) Tops Q4 EPS by 37c ; Offers Guidance
Jan 14, 2025 04:59AM Goldman Sachs Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
Jan 13, 2025 12:00PM BioMarin Pharma (BMRN) Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court
Dec 20, 2024 12:46PM BMO Capital Highlights Favorite Names for 2025 in Biotech
Dec 5, 2024 03:15PM BioMarin Pharma (BMRN) 6K contracts of January 6K puts trade at 60c and 65c
Nov 30, 2024 04:00AM Is Trump 2.0 good or bad for healthcare stocks?
Oct 30, 2024 07:18AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $65 at Baird
Oct 30, 2024 07:01AM William Blair Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Market Perform
Oct 30, 2024 06:53AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $84 at Canaccord Genuity
Oct 30, 2024 06:26AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $105 at Leerink Partners
Oct 30, 2024 05:48AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $81 at Citi
Oct 29, 2024 04:05PM BioMarin Pharma (BMRN) Tops Q3 EPS by 38c; raises guidance
Oct 10, 2024 08:20AM Raymond James Resumes BioMarin Pharmaceutical Inc. (BMRN) at Outperform
Oct 4, 2024 07:52AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $86 at Barclays
Oct 4, 2024 04:57AM Increasing unusual put option volume: EVGO LEVI ASHR EQT BMRN FUTU
Sep 25, 2024 05:38AM Goldman Sachs Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
Sep 18, 2024 04:10PM Citi Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
Sep 17, 2024 08:17AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $78 at Scotiabank
Sep 17, 2024 07:05AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $90 at Truist Securities
Sep 17, 2024 06:19AM Baird Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
View More Recent Stories View Older Stories